Fourth Joint Sectoral Group (JSG) Meeting of the Protocol to the Comprehensive Economic and Trade Agreement (CETA) between the European Union and Canada on the Mutual Recognition of the Compliance and Enforcement Programs regarding Good Manufacturing Practices (GMP) for Pharmaceutical Products
November 18, 2021, by videoconference, 10.30 to 12.00 Ottawa time- 16.30 to 18.00 Brussels time
- Introduction and adoption of the agenda
- Welcoming Remarks
- CETA regulatory cooperation forum (RCF): recognition of third countries drug facility inspections conducted by each party.
- Extension of the operational scope of the CETA protocol for pharmaceuticals to include active pharmaceutical ingredients (API).
- Impact of Covid-19
- Updates from Health Canada, the European Medicines Agency and the European Commission.
- Follow-up actions.
- Next meeting
Report a problem on this page
- Date Modified: